| L00897 | |
|
|
|
| 询价 | |
|
|
|
|
|
|
| 联系我们 | |
| Product Description |
The CytoSinct TCR αβ
Nanobeads, human is used for in vitro depletion of TCRα/β+ cells from
fresh or frozen peripheral blood mononuclear cells (PBMCs), leukapheresis
products or single cell suspension based on the surface expression of human
TCRα/β. To begin the isolation, Nanobeads are added to the cells. The cells/beads mixed suspension is loaded onto a CytoSinct Column placed in the CytoSinct magnet, or other compatible columns with a magnet. TCRα/β+ cells labeled with Nanobeads are retained within the column and unlabelled cells (TCRα/β- cells) are flushed out during the wash step. After removal of the magnetic field, the retained TCRα/β+ cells can be eluted as the positively selected cell fraction. |
| Capacity |
|
||||||||||||
| Format |
Supplied
in phosphate-buffered saline (PBS), containing Human Serum Albumin (HSA) and
Poloxamer 188. |
||||||||||||
| Components |
1 mL or 7.5 mL CytoSinct
TCR αβ Nanobeads, human Nanobeads conjugated to monoclonal anti-human TCRα/β antibodies. |
||||||||||||
| Storage |
Store at 2-8 °C. Do not
freeze. |
For research use only. Not intended for human and animal therapeutic or diagnostic use.
